| Followers | 13 |
| Posts | 855 |
| Boards Moderated | 0 |
| Alias Born | 03/22/2022 |
Wednesday, October 18, 2023 10:01:49 AM
After reading the 8-k and phase 2 results back in with a full position at .54
This has a high probability of going parabolic on phase 3 passing results after analyzing phase 2 results
22% ownership and 11 million market cap with a previous price target of $20
Tomorrow the 19th is the presentation and venture capitalists that think the same will be buying after the conference
Going to stay long this for the big win
GLTA
This has a high probability of going parabolic on phase 3 passing results after analyzing phase 2 results
22% ownership and 11 million market cap with a previous price target of $20
Tomorrow the 19th is the presentation and venture capitalists that think the same will be buying after the conference
Going to stay long this for the big win
GLTA
Bullish
Recent PCSA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:54:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:52:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:51:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:50:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:12:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:17:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:08:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:06:41 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/23/2026 04:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:07:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:05:30 PM
- Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/12/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 01:30:50 PM
- Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study • GlobeNewswire Inc. • 01/05/2026 02:15:00 PM
- Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update • IH Market News • 12/17/2025 03:10:16 PM
- Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer • GlobeNewswire Inc. • 12/17/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 04:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:07:39 PM
- Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 • GlobeNewswire Inc. • 11/05/2025 02:15:00 PM
